Ultima Anastro

Anastrozole is a highly effective anti-estrogen agent classified under the Aromatase Inhibitor (AI) category. Arimidex has demonstrated superior efficacy in the treatment of breast cancer compared to traditional agents like Nolvadex (Tamoxifen Citrate) and is widely favored among anabolic steroid users for its estrogen-blocking capabilities. Many individuals utilizing anabolic steroids depend on Arimidex during their cycles to mitigate estrogen-related effects.

As an anti-estrogen, Arimidex is essential for breast cancer patients since many cancer types can thrive on estrogen hormones. In a simplified way, administering Arimidex can help "starve" the cancer of estrogen. In recent years, it has established itself as the leading anti-estrogen treatment for hormone receptor-positive breast cancer, particularly in post-menopausal women.

For those using anabolic steroids, Arimidex's protective effects against estrogen-related side effects are greatly valued. Many anabolic steroids may lead to estrogenic side effects due to the conversion of testosterone by the aromatase enzyme. As aromatization occurs, estrogen levels rise, potentially causing issues like gynecomastia and significant water retention, which can also contribute to elevated blood pressure. Not all anabolic steroids aromatize, therefore not all will produce estrogen-related side effects.

Using Arimidex during a steroid cycle that includes aromatizing steroids can help prevent gynecomastia and excessive water retention, subsequently protecting against high blood pressure as well. Without a doubt, AIs like Arimidex are the most effective agents to counter estrogen-related side effects. While SERMs such as Nolvadex can also be effective and are generally preferable, Arimidex may have adverse effects on cholesterol, which we will discuss in the side effects section. Nonetheless, cholesterol-related issues can often be minimized.

Due to its testosterone-boosting properties, Arimidex may also appeal to those undergoing low testosterone treatment and for Post Cycle Therapy (PCT) in anabolic steroid users. In instances of low testosterone therapy, it might not be entirely sufficient on its own, but it can still be helpful when used alongside testosterone replacement to guard against estrogenic side effects. In terms of PCT, while some may find success with it, it is generally not advised. The primary aim of a PCT regimen is to stimulate the body’s natural testosterone production, thereby preserving lean muscle mass, controlling body fat, and promoting overall health. However, achieving normalization is hindered when using Arimidex post-cycle due to its strong estrogen-lowering effects. Although elevated estrogen levels can be a concern, a certain amount of estrogen is necessary for proper bodily functions, especially concerning the immune system and cardiovascular health. Therefore, for steroid users, AIs should be reserved for use during cycles, with SERMs recommended for PCT instead.

In the context of breast cancer treatment, Arimidex is typically prescribed at a dosage of 1mg per day until the cancer is in remission. Treatment may continue for a period after remission, often transitioning to Nolvadex as a precautionary measure.

For anabolic steroid users, the typical Arimidex dosage ranges from 0.5 to 1mg every other day. Most individuals will find that they do not need more than 1mg every other day, and many will do well with only half that dosage. In therapeutic scenarios like low testosterone treatment, even less may be sufficient. However, competitive bodybuilders might consider a full 1mg daily for the last 10-14 days before a competition to enhance muscle definition, although this can be quite draining. At this point in a competition diet, many bodybuilders are already low on energy.